Spruce Biosciences, Inc. (SPRB) bonds
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$40.49−1.76 (-4.17%)
Close on Nov 17, 2026Market cap $116.37MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$7.09M
$2.50M due within a year
Net debt
-$89.20M
After $96.30M of cash
Implied interest rate
10.31%
FY2025 interest ÷ average debt
Interest coverage
-405.7×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2024
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Spruce Biosciences's 10-Q for the period ended Jul 1, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| After the first anniversary | 2.00% | – | – |
| After the second anniversary | 4.00% | – | – |
| Avenue Loan Convertible at $60 a share | – | – | $7.10M |
| Prior to the first anniversary | 3.00% | – | – |
| Prior to the second anniversary | 1.00% | – | – |
| Tranche 1 | – | $15.00M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Second Tranche Term Loan | $10.00M |
See a number that looks wrong?